{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"diffuse-midline-glioma-h3-k27-altered","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A diffuse midline glioma characterized by H3 K27 alteration and usually either a histone H3 K27M mutation, an EGFR mutation, or aberrant overexpression of EZHIP. The prognosis is poor.","mondoId":"MONDO:1060171","node":{"canonicalSlug":"diffuse-midline-glioma-h3-k27-altered","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"diffuse midline glioma, H3 K27-altered","paragraphs":["A diffuse midline glioma characterized by H3 K27 alteration and usually either a histone H3 K27M mutation, an EGFR mutation, or aberrant overexpression of EZHIP. The prognosis is poor."],"scope":"exact","source":"MONDO","upstream":"NCIT:C185368","url":"https://monarchinitiative.org/MONDO:1060171"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"diffuse intrinsic pontine glioma","mondoId":"MONDO:0006033","slug":"diffuse-intrinsic-pontine-glioma"},{"kind":"child","label":"diffuse midline glioma, H3 K27M-mutant","mondoId":"MONDO:0957196","slug":"diffuse-midline-glioma-h3-k27m-mutant"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/28173"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:1060171\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C185368</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A diffuse midline glioma characterized by H3 K27 alteration and usually either a histone H3 K27M mutation, an EGFR mutation, or aberrant overexpression of EZHIP. The prognosis is poor.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:1060171\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"diffuse-midline-glioma-h3-k27-altered","sourceDocuments":[{"name":"MONDO: diffuse midline glioma, H3 K27-altered","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:1060171"}],"sourceNote":"","synonyms":["DMG, H3 K27-altered"],"takeawayHtml":"","title":"diffuse midline glioma, H3 K27-altered"},"schemaVersion":1}
